Findings

What do systematic reviews say?

8 questions · 8 findings · 2 reviews

No studies found 4 · 50%GRADE not reported 2 · 25%Very low 0 · 0%Low 0 · 0%Moderate 2 · 25%High 0 · 0%

Satisfaction · people with transfusion‐dependent thalassemia

The review found no eligible studies for this question.

1 finding from 1 review

Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Satisfaction · patients with managing transfusional iron overload in people with sickle cell disease

Deferasirox probably leads to higher satisfaction compared with deferoxamine (moderate certainty).

1 finding from 1 review

Deferasirox for managing transfusional iron overload in people with sickle cell disease 2014 · Cochrane Headline outcomes only
RR 3.13 [1.99, 4.93]
1 study · 195 participants
Moderate

Satisfaction with treatment · people with non‐transfusion‐dependent thalassemia

The review found no eligible studies for this question.

1 finding from 1 review

Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Satisfaction with treatment · people with transfusion‐dependent thalassemia

1 finding from 1 review

Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
no estimate extracted
1 participants
GRADE not reported

Participant satisfaction (very satisfied or satisfied) · people with transfusion‐dependent thalassemia

Deferasirox probably leads to higher satisfaction with treatment (very satisfied or satisfied):… compared with deferoxamine (moderate certainty).

1 finding from 1 review

Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
RR 2.2 [1.89, 2.57]
1 study · 571 participants
Moderate

Satisfaction · people with transfusion‐dependent thalassemia

The review found no eligible studies for this question.

1 finding from 1 review

Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Satisfaction with treatment · people with transfusion‐dependent thalassemia

The review found no eligible studies for this question.

1 finding from 1 review

Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Satisfaction with treatment · people with transfusion‐dependent thalassemia

1 finding from 1 review

Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only
no estimate extracted
1 participants
GRADE not reported